GT Healthcare Capital Partners

Overview

GT Healthcare Capital Partners is a private equity firm specializing in healthcare investments across Asia, with a strong presence in China. The firm focuses on providing capital and expertise to healthcare businesses, aiming to transform technology landscapes in the industry. GT Healthcare Capital Partners has launched AI-driven drug development companies and entered into collaborations to accelerate drug discovery processes. The firm has invested in companies such as GT Apeiron Therapeutics, a biotechnology company utilizing artificial intelligence for drug discovery, and has a history of supporting innovative healthcare ventures in the region. GT Healthcare Capital Partners is led by experienced professionals with backgrounds in healthcare investment and corporate finance, including individuals like Alan Au, the founder and managing partner, and Dr. Mingxi Li, a partner with expertise in life sciences and the China healthcare market. The firm's portfolio includes investments in various sectors within the healthcare industry, reflecting its commitment to advancing healthcare through strategic investments and partnerships. GT Healthcare Capital Partners continues to seek opportunities to invest in and support healthcare companies across Asia, leveraging its expertise and network to drive growth and innovation in the sector.

Investment Focus

• Focus on healthcare and technology sectors
• Preference for companies with innovative technologies
• Interest in cross-border investment opportunities
• Emphasis on market scalability in Asia/Greater China region
• Alignment with firm's investment strategy and values

Portfolio Companies